Načítá se...
Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Combination: Theory and Practice
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers are commonly used to treat hypertension and/or a range of progressive end‐organ diseases. The success of each of these drug classes in disease‐state management is without dispute, and has led to speculation that given togethe...
Uloženo v:
| Vydáno v: | J Clin Hypertens (Greenwich) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Le Jacq Communications, Inc.
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8099303/ https://ncbi.nlm.nih.gov/pubmed/11723362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2001.00678.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|